• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病发病队列在前4至14年随访期间视网膜病变的患病率和严重程度低于预期:威斯康星糖尿病登记研究

Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study.

作者信息

Lecaire Tamara, Palta Mari, Zhang Hongling, Allen Catherine, Klein Ronald, D'Alessio Donn

机构信息

Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, 53726, USA.

出版信息

Am J Epidemiol. 2006 Jul 15;164(2):143-50. doi: 10.1093/aje/kwj166. Epub 2006 May 26.

DOI:10.1093/aje/kwj166
PMID:16731577
Abstract

The authors examined the development of diabetic retinopathy in a population-based cohort of persons with incident type 1 diabetes to investigate the possibility of lowered retinopathy prevalence and severity compared with previous US studies. A total of 474 diabetic persons from Wisconsin were followed from diagnosis through 4-14 years' duration during 1990-2002. Retinopathy was determined by fundus photography at 4, 7, 9, and 14 years' duration. Risk of developing retinopathy was modeled on demographic and diabetes-care characteristics by means of a generalized linear model using the complementary log-log link for interval-censored data. Prevalence of retinopathy increased with duration of diabetes, from 6% at 4 years to 73% at 14 years, and was highest among adults (> or =20 years of age). Risk of developing retinopathy increased with increasing duration, worse glycemic control, and age up to 20 years. Indicators of diabetes care were related to retinopathy through their effect on glycemic control. Improvements in diabetes care leading to better glycemic control may have contributed to the much lower prevalence and less severe retinopathy observed than expected on the basis of a previous report from the same region of Wisconsin. The observed decreased prevalence has important implications for persons with type 1 diabetes, since retinopathy is a serious microvascular complication.

摘要

作者对一个基于人群的1型糖尿病新发患者队列中的糖尿病视网膜病变发展情况进行了研究,以调查与美国此前的研究相比,视网膜病变患病率和严重程度降低的可能性。1990年至2002年期间,对来自威斯康星州的474名糖尿病患者从确诊开始进行了4至14年的随访。在病程4年、7年、9年和14年时通过眼底照相确定是否患有视网膜病变。采用广义线性模型,利用互补对数-对数链接对区间删失数据,根据人口统计学和糖尿病护理特征对发生视网膜病变的风险进行建模。视网膜病变的患病率随糖尿病病程增加而上升,从4年时的6%升至14年时的73%,在成年人(≥20岁)中最高。发生视网膜病变的风险随病程延长、血糖控制变差以及年龄在20岁之前的增长而增加。糖尿病护理指标通过对血糖控制的影响与视网膜病变相关。糖尿病护理的改善导致血糖控制更好,这可能是观察到的患病率远低于预期且视网膜病变严重程度低于基于威斯康星州同一地区此前报告所预期的原因。观察到的患病率下降对1型糖尿病患者具有重要意义,因为视网膜病变是一种严重的微血管并发症。

相似文献

1
Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study.1型糖尿病发病队列在前4至14年随访期间视网膜病变的患病率和严重程度低于预期:威斯康星糖尿病登记研究
Am J Epidemiol. 2006 Jul 15;164(2):143-50. doi: 10.1093/aje/kwj166. Epub 2006 May 26.
2
Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.评估 1 型糖尿病视网膜病变结局的进展:威斯康星州糖尿病登记研究与威斯康星州糖尿病性视网膜病变流行病学研究结果的比较。
Diabetes Care. 2013 Mar;36(3):631-7. doi: 10.2337/dc12-0863. Epub 2012 Nov 27.
3
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:XXII 1型糖尿病患者视网膜病变的25年进展情况
Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
4
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究XXIII:1型糖尿病患者黄斑水肿的25年发病率
Ophthalmology. 2009 Mar;116(3):497-503. doi: 10.1016/j.ophtha.2008.10.016. Epub 2009 Jan 22.
5
Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes.胰岛素依赖型糖尿病确诊后视网膜病变的发病率及相关危险因素。
Arch Ophthalmol. 1997 Mar;115(3):351-6. doi: 10.1001/archopht.1997.01100150353007.
6
The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.炎症和内皮功能障碍标志物与糖尿病视网膜病变的患病率及进展的关系:威斯康星糖尿病视网膜病变流行病学研究
Arch Ophthalmol. 2009 Sep;127(9):1175-82. doi: 10.1001/archophthalmol.2009.172.
7
Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.血清脂质与长期 1 型糖尿病患者的增殖性糖尿病视网膜病变和黄斑水肿:威斯康星州糖尿病视网膜病变流行病学研究。
JAMA Ophthalmol. 2015 May;133(5):503-10. doi: 10.1001/jamaophthalmol.2014.5108.
8
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).糖尿病青年成人患者确诊10年后视网膜病变的发病率:瑞典全国性基于人群的糖尿病发病率研究(DISS)结果
Diabetes Care. 2003 Feb;26(2):349-54. doi: 10.2337/diacare.26.2.349.
9
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.威斯康星糖尿病视网膜病变流行病学研究。II. 诊断时年龄小于30岁的糖尿病视网膜病变患病率及风险
Arch Ophthalmol. 1984 Apr;102(4):520-6. doi: 10.1001/archopht.1984.01040030398010.
10
Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.氧化型低密度脂蛋白与增殖性糖尿病视网膜病变及由眼底照片确定的临床显著性黄斑水肿的发生率
JAMA Ophthalmol. 2015 Sep;133(9):1054-61. doi: 10.1001/jamaophthalmol.2015.2239.

引用本文的文献

1
Comparison of broadband and monochromatic photopic negative response in eyes of patients with diabetes with no diabetic retinopathy and different stages of diabetic retinopathy.糖尿病性视网膜病变不同阶段及无糖尿病性视网膜病变的糖尿病患者眼中宽带与单色明视觉负反应的比较。
Indian J Ophthalmol. 2021 Nov;69(11):3241-3248. doi: 10.4103/ijo.IJO_988_21.
2
Diabetic Retinopathy in Children with Type 1 Diabetes-Occurrence and Screening Using Optical Coherence Tomography.1型糖尿病患儿的糖尿病视网膜病变——光学相干断层扫描技术在发病情况及筛查中的应用
Life (Basel). 2021 Jun 21;11(6):590. doi: 10.3390/life11060590.
3
Risk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of age.
18 岁以下被诊断为 1 型糖尿病的患者首次筛查时发生糖尿病视网膜病变的危险因素。
Eye (Lond). 2021 Oct;35(10):2840-2847. doi: 10.1038/s41433-020-01326-8. Epub 2020 Dec 1.
4
Analysis of Retinal Perfusion in Children, Adolescents, and Young Adults with Type 1 Diabetes Using Optical Coherence Tomography Angiography.1 型糖尿病儿童、青少年和年轻成人的视网膜血流分析:应用光学相干断层血管造影术。
J Diabetes Res. 2019 May 8;2019:5410672. doi: 10.1155/2019/5410672. eCollection 2019.
5
Complications of Diabetes Diagnosed in Children and Adolescents-Reply.儿童及青少年糖尿病诊断的并发症——回复
JAMA. 2017 Jun 27;317(24):2553-2554. doi: 10.1001/jama.2017.6243.
6
The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study.1型糖尿病中增殖性糖尿病视网膜病变、大量蛋白尿和周围神经病变患病率的时期效应:一项纵向队列研究。
PLoS One. 2017 Mar 31;12(3):e0174979. doi: 10.1371/journal.pone.0174979. eCollection 2017.
7
Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population.糖尿病视网膜病变的观察变化:西班牙人群的八年随访
Br J Ophthalmol. 2016 Oct;100(10):1366-71. doi: 10.1136/bjophthalmol-2015-307689. Epub 2016 Jan 14.
8
Ocular Complications in Children with Diabetes Mellitus.糖尿病患儿的眼部并发症
Ophthalmology. 2015 Dec;122(12):2457-64. doi: 10.1016/j.ophtha.2015.07.010. Epub 2015 Sep 1.
9
Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration.1型糖尿病病程20年期间脂联素的纵向分析
J Diabetes Res. 2015;2015:730407. doi: 10.1155/2015/730407. Epub 2015 Apr 9.
10
Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review.1型糖尿病青年患者血管并发症的患病率及其发生的预测因素:系统文献综述
BMC Res Notes. 2014 Sep 2;7:593. doi: 10.1186/1756-0500-7-593.